Latest Breaking News On - Kalvista pharmaceuticals stock down - Page 1 : vimarsana.com

AJOVista LLC Acquires Shares of 4,920 KalVista Pharmaceuticals, Inc (NASDAQ:KALV)

AJOVista LLC Acquires Shares of 4,920 KalVista Pharmaceuticals, Inc (NASDAQ:KALV)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkBenjaminl palleikoKalvista pharmaceuticals incNeedham companyKalvista pharmaceuticals company profileQuarter for kalvista pharmaceuticalsChina universal asset management coSecurities exchange commissionKalvista pharmaceuticals stock downInsider transactions at kalvista pharmaceuticalsKalvista pharmaceuticalsPrincipal financial group incYork state common retirement fundExchange commissionNews ratings for kalvista pharmaceuticals daily

KalVista Pharmaceuticals (NASDAQ:KALV) Price Target Cut to $20 00

KalVista Pharmaceuticals (NASDAQ:KALV) Price Target Cut to $20 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesBenjaminl palleikoKalvista pharmaceuticalsNews ratings for kalvista pharmaceuticals dailyNan fung group holdings ltdFrazier life sciences managementKalvista pharmaceuticals company profileNeedham companySg americas securitiesAffinity asset advisorsKalvista pharmaceuticals stock downKalvista pharmaceuticals incInsider transactions at kalvista pharmaceuticalsSecurities exchange commissionVanguard group incGet free report

KalVista Pharmaceuticals, Inc (NASDAQ:KALV) CFO Benjamin L Palleiko Sells 22,802 Shares of Stock

KalVista Pharmaceuticals, Inc (NASDAQ:KALV) CFO Benjamin L Palleiko Sells 22,802 Shares of Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesBenjaminl palleikoSecurities exchange commissionKalvista pharmaceuticalsQuarter for kalvista pharmaceuticalsNeedham companyKalvista pharmaceuticals incNews ratings for kalvista pharmaceuticals dailyMetlife investment managementYork mellon corpKalvista pharmaceuticals stock downBlackrock incJpmorgan chase coGet free reportExchange commissionVista pharmaceuticals stock down

Insider Buying: KalVista Pharmaceuticals, Inc (NASDAQ:KALV) Major Shareholder Purchases $604,359 00 in Stock

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) major shareholder Venrock Healthcare Capital Par purchased 47,700 shares of KalVista Pharmaceuticals stock in a transaction that occurred on Wednesday, January 10th. The shares were acquired at an average price of $12.67 per share, with a total value of $604,359.00. Following the acquisition, the insider now directly […]

United statesMorgan stanleyKalvista pharmaceuticals incSaturnv capital managementQuarter for kalvista pharmaceuticalsNews ratings for kalvista pharmaceuticals dailyBoxer capitalKalvista pharmaceuticals stock downInstitutional investors weigh in on kalvista pharmaceuticalsGreat point partnersKalvista pharmaceuticalsGet free reportVenrock healthcare capital parHealthcare capital parVista pharmaceuticals stock downVista pharmaceuticals

KalVista Pharmaceuticals, Inc Expected to Post Q2 2024 Earnings of ($0 66) Per Share (NASDAQ:KALV)

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Free Report) – Research analysts at Leerink Partnrs boosted their Q2 2024 EPS estimates for shares of KalVista Pharmaceuticals in a research report issued on Thursday, September 7th. Leerink Partnrs analyst J. Schwartz now expects that the specialty pharmaceutical company will earn ($0.66) per share for the quarter, up from […]

Hong kongUnited statesLeerink partnrsThomas andrew crockettBenjaminl palleikoCantor fitzgeraldNews ratings for kalvista pharmaceuticals dailyKalvista pharmaceuticals stock downBarclays plcKalvista pharmaceuticals incKalvista pharmaceuticalsHong kong ltdInstitutional investors weigh in on kalvista pharmaceuticalsSecurities exchange commissionRoyal bankFree report